Nanoparticle Manufacturing Update

Matthew Wygant Investor Updates, News

Imagion Biosystems is pleased to provide an update on its progress and plans for manufacturing of its proprietary nanoparticle formulation in advance of the first in human study currently planned for mid-2020.

Read the update.